Texas Capital Bancshares Inc/Tx (TCBIO) Share-based Compensation (2011 - 2026)

Texas Capital Bancshares (TCBIO) has reported Share-based Compensation for 16 consecutive years, with $9.8 million the latest figure, recorded in Q2 2026.

• Quarterly Share-based Compensation rose 28.15% year-over-year to $9.8 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $43.7 million (up 44.0% YoY) and the FY2025 annual result came in at $36.8 million, up 48.86% from the prior year.
• Share-based Compensation fell to $9.8 million in Q2 2026 per TCBIO's latest filing, from $17.5 million in the prior quarter.
• Over the last five years, Share-based Compensation for TCBIO reached as high as $17.5 million in Q1 2026 and fell as low as $3.5 million in Q4 2024.
• A 5-year average of $7.5 million and a median of $6.4 million in 2023 frame the typical range for Share-based Compensation.
• Annual changes were most pronounced in 2024 — Share-based Compensation slumped 44.26% — and 2025, when it surged 133.72%.
• Year by year, Share-based Compensation stood at $5.4 million in 2022, then rose by 14.91% to $6.3 million in 2023, then sank by 44.26% to $3.5 million in 2024, then surged by 133.72% to $8.1 million in 2025, then climbed by 20.0% to $9.8 million in 2026.
• According to Business Quant data, Share-based Compensation over the past three periods registered $9.8 million, $17.5 million, and $8.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.